NEW YORK, Dec. 11, 2012 \/PRNewswire\/ -- Reportlinker.com announces that a new market research report is available in its catalogue: <\/p>\n
Global Regenerative Medicine Industry http:\/\/www.reportlinker.com\/p090567\/Global-Regenerative-Medicine-Industry.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Blood_Supply,_Tissue_Banking_and_Transplantation<\/a> <\/p>\n This report analyzes the worldwide markets for Regenerative Medicine in US$ million. The report provides separate comprehensive analytics for the US, Europe, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. A six-year historic analysis is also provided for these markets. The report profiles 93 companies including many key and niche players such as BioVest International, Inc., Curis, Inc., Cytori Therapeutics, Inc., Evotec AG, Forticell Bioscience, Inc., Geron Corporation, Integra LifeSciences Corporation, LifeCell Corporation, Osiris Therapeutics, Inc., Tengion, Inc., Tepha Inc., and TiGenix N.V. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based upon search engine sources in the public domain. <\/p>\n I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS Study Reliability and Reporting Limitations I-1 Disclaimers I-2 Data Interpretation & Reporting Level I-2 Quantitative Techniques & Analytics I-3 Product Definitions and Scope of Study I-3 <\/p>\n II. EXECUTIVE SUMMARY <\/p>\n 1. INDUSTRY OVERVIEW II-1 A Primer II-1 Current and Future Analysis II-1 Current Global Market for Regenerative Medicine II-2 Therapeutic Companies and Products in Regenerative Medicine - Current Status II-2 Select Therapeutic Regenerative Medicine Products in the Global Market II-3 Market Potential II-3 <\/p>\n 2. REGENERATIVE MEDICINE IN BONE AND JOINT APPLICATIONS II-5 An Overview of Regenerative Medicine in Bone and Joint Applications II-5 Bone Graft Substitutes - Penetration in Foot and Ankle Surgeries II-5 Repair of Non-Healing Bones - High Market Potential II-5 Market Potential of Bone Graft Substitutes (BGSs) II-6 Table 1: Global Bone Graft Substitute Market (2010): Percentage Share Breakdown of Sales for DePuy, OrthoVita, ApaTech\/Baxter, Wright Medical, Medtronic\/RTI, Biomet, and Others (includes corresponding Graph\/Chart) II-6 Synthetic Bone Graft Substitutes to Replace Traditional Autografts and Allografts II-6 Select Synthetic Products in Orthobiologics II-7 Bone Morphogenic Proteins (BMPs) Gaining Popularity II-7 Bone Morphogenic Protein products in Orthobiology II-7 Table 2: Global Bone Morphogenic Protein Market (2010): Percentage Share Breakdown of Sales for Medtronic\/RTI, and Stryker (includes corresponding Graph\/Chart) II-7 Demineralized Bone Matrices (DBMs) Market Getting Crowded II-8 Table 3: Global Demineralized Bone Matrix Market (2011): Percentage Share Breakdown of Value Sales for Medtronic\/RTI, Synthes\/MTF, Integra LifeSciences, Altiva, Bacterin, and Others (includes corresponding Graph\/Chart) II-8 Select DBM products in Orthobiologics market II-8 Biomaterials Market - Promising Opportunities for Cost- Effective Products II-8 Existing Bone Graft Procedures - Limitations and Concerns II-9 Autograft Procedures II-9 Allograft - DBM and Other Allografts II-9 BMPs and Other Synthetic Growth Factors II-9 Medical Devices and Implants for Orthopedics II-10 Expanding Opportunities in Hip and Knee Market II-10 Extremity Reconstruction - A Growing Market II-10 Tissue Engineered Cartilage Market - An Overview II-11 Tissue Engineered Cartilages - A Promising Solution for Cartilage Repair II-11 Market Potential of Tissue Engineered Cartilage Products II-11 Potential Applications of Tissue Engineered Cartilage Products II-11 Commercially Available tissue engineered cartilage products II-12 Challenges in Clinical Application of Tissue Engineered Cartilage Products II-13 Bone Marrow Transplants (BMTs) II-13 Market Potential for BMTs II-14 Companies Engaged in CBSC Research for BMTs II-14 Table 4: Global Orthobiologics Market (2010): Percentage Share Breakdown of Value Sales for Medtronic\/RTI, Synthes\/MTF, DePuy, Osteotech, Orthofix, and Others (includes corresponding Graph\/Chart) II-14 <\/p>\n Table 5: Global Orthobiologics Market (2010): Percentage Share Breakdown of Value Sales by Product Type for Growth Factors, Synthetics, DMBs, Allografts, and Stem Cells (includes corresponding Graph\/Chart) II-15 <\/p>\n Table 6: Global Machined Bone and Allograft Market (2010): Percentage Share Breakdown of Value Sales for Synthes\/MTF, DePuy, Medtronic\/RTI, Osteotech, RTIX, and Others (includes corresponding Graph\/Chart) II-15 <\/p>\n Table 7: Global Stem Cell Orthobiologics Market (2010): Percentage Share Breakdown of Value Sales for Nuvasive, and Otrhofix includes corresponding Graph\/Chart) II-15 <\/p>\n <\/p>\n Originally posted here:<\/p>\n Global Regenerative Medicine Industry<\/a><\/p>\n","protected":false},"excerpt":{"rendered":" NEW YORK, Dec. Continue reading